相关实验视频
Updated: May 10, 2026

Using SCOPE to Identify Potential Regulatory Motifs in Coregulated Genes
Published on: May 31, 2011
基因疗法的科学进展:全球监管趋同的机遇
Jimi Olaghere1, David A Williams2,3, Jeremy Farrar4
1Sugarloaf Capital, Atlanta, GA 30309, USA.
基因治疗的科学进步,包括CRISPR,提供了希望,但在低收入国家面临进入障碍. 全球监管趋同对于公平获得这些拯救生命的治疗方法至关重要.
科学领域:
- 生物技术和生物医学科学 生物技术和生物医学科学
- 遗传学和基因组学 遗传学和基因组学
- 监管科学 监管科学
背景情况:
- 基因疗法的快速进步,包括基于CRISPR的技术,导致FDA批准的治疗方法.
- 在获得这些先进疗法方面存在重大差异,特别是在低收入和中等收入国家 (LMICs).
- 状细胞疾病 (SCD) 被用作一个模型来探索资源不足地区的基因疗法获取挑战.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
09:44Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
相关概念视频
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Pharmacogenomics: Identification of New Drug Targets
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Microorganisms in Medicine and Therapeutics
Global Regulatory Systems